Cargando…
β-d-N(4)-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Mutagenic ribonucleosides can act as broad-based antiviral agents. They are metabolized to the active ribonucleoside triphosphate form and concentrate in genomes of RNA viruses during viral replication. β-d-N(4)-hydroxycytidine (NHC, initial metabolite of molnupiravir) is >100-fold more active th...
Autores principales: | Zhou, Shuntai, Hill, Collin S, Sarkar, Sanjay, Tse, Longping V, Woodburn, Blaide M D, Schinazi, Raymond F, Sheahan, Timothy P, Baric, Ralph S, Heise, Mark T, Swanstrom, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136050/ https://www.ncbi.nlm.nih.gov/pubmed/33961695 http://dx.doi.org/10.1093/infdis/jiab247 |
Ejemplares similares
-
Reply to Troth et al
por: Zhou, Shuntai, et al.
Publicado: (2021) -
Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation
por: Woodburn, Blaide M., et al.
Publicado: (2022) -
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
por: Hadj Hassine, Ikbel, et al.
Publicado: (2022) -
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody
por: Zibat, Arne, et al.
Publicado: (2023) -
Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs
por: Bassi, Maria Rosaria, et al.
Publicado: (2018)